Denali Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,100
| Closed | -$12.6K | – | 517 |
|
|
2023
Q3 | $12.6K | Hold |
1,100
| – | – | ﹤0.01% | 361 |
|
|
2023
Q2 | $27.8K | Hold |
1,100
| – | – | 0.01% | 320 |
|
|
2023
Q1 | $35.4K | Sell |
1,100
-1,200
| -52% | -$38.7K | 0.01% | 251 |
|
|
2022
Q4 | $42.5K | Sell |
2,300
-2,200
| -49% | -$40.6K | 0.02% | 243 |
|
|
2022
Q3 | $122K | Sell |
4,500
-1,000
| -18% | -$27.1K | 0.06% | 159 |
|
|
2022
Q2 | $76K | Sell |
5,500
-1,000
| -15% | -$13.8K | 0.03% | 186 |
|
|
2022
Q1 | $127K | Hold |
6,500
| – | – | 0.05% | 179 |
|
|
2021
Q4 | $106K | Buy |
+6,500
| New | +$106K | 0.04% | 188 |
|